- $546.63m
- $404.45m
- $418.63m
Brief: MiMedx Appoints Doug Rice As Chief Financial Officer
Brief: MiMedx Group Says Robert Stein’s Position As President Of Regenerative Medicine Business Unit Eliminated, And He Will Be Departing From The Company
Brief: MIMEDX Announces Strategic Realignment
MiMedx Group Inc reports results for the quarter ended in March - Earnings Summary
Brief: Mimedx Announces First Quarter 2023 Operating And Financial Results
Brief: MiMedx posts Q1 sales of USD 71.676 million
MiMedx Group Inc expected to post a loss of 9 cents a share - Earnings Preview
Brief: MiMedx Group Announces Chief Financial Officer Transition
Brief: MiMedx Reports Q4 sales $74.375 Million
Brief: Mimedx Announces Fourth Quarter And Full Year 2022 Operating And Financial Results
MiMedx Group Inc reports results for the quarter ended in December - Earnings Summary
MiMedx Group Inc expected to post a loss of 4 cents a share - Earnings Preview
Brief: Mimedx Appoints Joseph Capper As CEO And Director
Brief: MiMedx Group Confirms Q4 Net Sales Expected In The Ranges Of $73 Million To $76 Million
Brief: Mimedx Announces Commercial Launch Of Epifix In Japan
Brief: MiMedx Announces Wound & Surgical Product Pipeline Expansion On Agreement With Turn Therapeutics
MiMedx Group Inc reports results for the quarter ended in September - Earnings Summary
Brief: Mimedx Announces Third Quarter 2022 Results
MiMedx Group Inc expected to post a loss of 8 cents a share - Earnings Preview